ARTICLE | Clinical News
Abbott, Enanta report HCV data
November 2, 2010 12:23 AM UTC
Abbott Laboratories (NYSE:ABT) and partner Enanta Pharmaceuticals Inc. (Cambridge, Mass.) said once-daily ABT-450 plus Norvir ritonavir significantly reduced mean HCV RNA levels from baseline to day t...